rdiprima

[Ignacio J. Amat @ignamatsant]

TEAMWORK at #CTOLIVEAID2023
👆First Nagomi DES cases
😖Challenging CTO
🥇Succesful thank to a great team @Carlos_Cortes_V @jpsanchezluna

Thanks @GLGasparini for this great opportunity & @esbrilakis for his extremely useful comments

[Valeria Paradies @valeriaparadies]

@DrMarthaGulati @gbiondizoccai @AgostoniPF @rdiprima2 @terumoisuk @DrMarthaGulati it’s a fantastic program for young mid career IC. I couldn’t make it this time as a few of other WIC. @kiadeb87 @giuliamasiero3

[Valeria Paradies @valeriaparadies]

@gbiondizoccai @AgostoniPF @rdiprima2 @terumoisuk So sorry I couldn’t join this edition of bootcamp! I was part of the journey from the very beginning but unfortunate this time couldn’t leave the Cathlab! Thanks for supporting all-round skills of young- mid career interventional cardiologists :)

[rdiprima @rdiprima2]

@AnastasiaSMihai @gbiondizoccai @AgostoniPF @terumoisuk Unfortunately our gorgeous pink crew was not able to join us !! They are working in the cathlabs 😂💪🏻

[rdiprima @rdiprima2]

@DrMarthaGulati @gbiondizoccai @AgostoniPF @terumoisuk Many gorgeous, brilliant and powerful women have been part of the Bootcamp project! For a matter of chance they couldn’t join this meeting but we are proud to continuously support our physicians no matter if male or female… quality is not gender related 😉

[Giuseppe Biondi-Zoccai @gbiondizoccai]

"In MASTER DAPT adherent population, 1-month vs ≥3-month DAPT was associated with similar NACE or MACE and lower MCB. Among OAC patients, SAPT discontinuation after 6 months was associated with similar MACE and lower MCB than SAPT continuation"
https://t.co/wFK76s7aZJ
@vlgmrc

[Davide Capodanno @DFCapodanno]

Is there a plateau in the performance of modern DES, and does complex PCI remain a factor? The e-Ultimaster registry (n=35,839) emphasizes that the number and types of complex features still have an impact on the procedural outcomes of PCI. #EIJTopCited https://t.co/RR9wrHiDmH

[rdiprima @rdiprima2]

@ignamatsant @TAVRBot @PCRonline @shci_sec @ResiSec @JovenesSec @GilbertTangMD @DrArifK @adnanalkhouli @Sara_Blasco @jpsanchezluna @afcisnal @sjorge4 @JGCorSo @djc795 @CathElectroSurg I’m in love with such craft work !!!! 😍😍

[Carlo Tumscitz @skat_ct]

Another evidence that Radial beats femoral approach even in the toughest clinical setting. Honored to be among the authors and with my mentor @vlgmrc and many others https://t.co/JDTPRISdil

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Finecross-in-needle (FINE) technique: a novel approach to tackle challenging vascular access
Courtesy of Arturo Giordano and Raffaella Di Prima
@rdiprima2 @terumoisuk

[Terumo Interventional Systems @terumoisuk]

Proud to be supporting #JIM2022. Join us to gain more insights on Microcatheters for complex PCI: why, when and which one with A. Gagnor and about one month DAPT for one stent based on the trial: The Master DAPT with M. Valgimigli
👉 https://t.co/clYg1Vpyem

[rdiprima @rdiprima2]

@AndWierucki @gbiondizoccai Perfect example of good communication skills indeed 😂

[Terumo Interventional Systems @terumoisuk]

First results of the DIStal versus COnventional RADIAL access (DISCO RADIAL) clinical trial, a Terumo sponsored study, are now published in the Journal of the American College of Cardiology (JACC). Read more
📘 https://t.co/aegIRDNKe6
#radialfirst #cardiotwitter

[kazi ferdous @fazalabul]

solving knots

[Evandro Martins F. MD @evandrofilhobr]

Poor’s man DLC.

Possibily to track SB few millimeters.

[Alessandro Sticchi @Sticchi_Alex]

What you can do when you need a shorter GC and you don't have it in your lab?
OL tech:
-introducer of 1 Fr smaller than GC
-Cut off the length you need away from GC, starting from 5 cm from the prox part of the GD
-use 3 cm of the introducer as connection
@GLGasparini Masterclass

[Simon Sinek @simonsinek]

Communication is not about saying what we think. Communication is about ensuring others hear what we mean.

[Marco Valgimigli @vlgmrc]

MASTER DAPT among the trials of the year (and even twice mentioned!) thanks #ehj@esc_journals

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Marco Valgimigli highlights the strengths and take-home messages of the MASTER DAPT trial in the Science & Friends Scientific Meeting in Rome
@vlgmrc

[Giuseppe Biondi-Zoccai @gbiondizoccai]

This is the outstanding program of the think-tank on the MASTER DAPT trial supported by Terumo
@MattiaGalli10
@maxinrome @vlgmrc @terumoisuk